Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 37, Supplement A, May 1996   [Index by Author] 


Down Other Departments
Down Articles


[Search ALL Issues]

Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Other Departments Back

Roger Finch, Adrian Bint, Pam Hunter, and Les White
Preface
J. Antimicrob. Chemother. 1996 37: iii; doi:10.1093/jac/37.suppl_A.iii [PDF] [Request Permissions]  

Articles Back

Fernando Baquero and Rafael Cantón
In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens
J. Antimicrob. Chemother. 1996 37: 1-18; doi:10.1093/jac/37.suppl_A.1 [Abstract] [PDF] [Request Permissions]  

Evelio J. Perea, Javier Aznar, Mercedes C. Garcia-Iglesias, and Alvaro Pascual
Comparative in-vitro activity of sparfloxacin against genital pathogens
J. Antimicrob. Chemother. 1996 37: 19-25; doi:10.1093/jac/37.suppl_A.19 [Abstract] [PDF] [Request Permissions]  

Guy Montay
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
J. Antimicrob. Chemother. 1996 37: 27-39; doi:10.1093/jac/37.suppl_A.27 [Abstract] [PDF] [Request Permissions]  

Yasuyuki Mizuki, Iwao Fujiwara, and Toshikazu Yamaguchi
Pharmacokinetic interactions related to the chemical structures of fluoroquinolones
J. Antimicrob. Chemother. 1996 37: 41-55; doi:10.1093/jac/37.suppl_A.41 [Abstract] [PDF] [Request Permissions]  

R. Wise and D. Honeybourne
A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses
J. Antimicrob. Chemother. 1996 37: 57-63; doi:10.1093/jac/37.suppl_A.57 [Abstract] [PDF] [Request Permissions]  

E. Genevois, V. Lelouer, Jean-Baptiste Vercken, and R. Caillon
Study design, methodology and statistical analyses in the clinical development of sparfloxacin
J. Antimicrob. Chemother. 1996 37: 65-72; doi:10.1093/jac/37.suppl_A.65 [Abstract] [PDF] [Request Permissions]  

M. Aubier, H. Lode, G. Gialdroni-Grassi, G. Huchon, J. Hosie, N. Legakis, C. Regamey, S. Segev, R. Vester, W. J. Wijnands, and N. Tolstuchow
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies
J. Antimicrob. Chemother. 1996 37: 73-82; doi:10.1093/jac/37.suppl_A.73 [Abstract] [PDF] [Request Permissions]  

H. Portier, Th. May, A. Proust, and the French Study Group
Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia
J. Antimicrob. Chemother. 1996 37: 83-91; doi:10.1093/jac/37.suppl_A.83 [Abstract] [PDF] [Request Permissions]  

L. Allegra, N. Konietzko, P. Leophonte, J. Hosie, R. Pauwels, J. N. Guyen, and P. Petitpretz
Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study
J. Antimicrob. Chemother. 1996 37: 93-104; doi:10.1093/jac/37.suppl_A.93 [Abstract] [PDF] [Request Permissions]  

P. Gehanno, P. Berche, and The Sinusitis Study Group
Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis
J. Antimicrob. Chemother. 1996 37: 105-114; doi:10.1093/jac/37.suppl_A.105 [Abstract] [PDF] [Request Permissions]  

H. Moi, P. Morel, B. Gianotti, D. Barlow, Ian Phillips, and C. Jean
Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men
J. Antimicrob. Chemother. 1996 37: 115-122; doi:10.1093/jac/37.suppl_A.115 [Abstract] [PDF] [Request Permissions]  

I. Phillips, C. Dimian, D. Barlow, H. Moi, E. Stolz, W. Weidner, and E. Perea
A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men
J. Antimicrob. Chemother. 1996 37: 123-134; doi:10.1093/jac/37.suppl_A.123 [Abstract] [PDF] [Request Permissions]  

Kurt G. Naber, F. Di Silveriob, A. Geddes, and J. Guibert
Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection
J. Antimicrob. Chemother. 1996 37: 135-144; doi:10.1093/jac/37.suppl_A.135 [Abstract] [PDF] [Request Permissions]  

Ethan Rubinstein
Safety profile of sparfloxacin in the treatment of respiratory tract infections
J. Antimicrob. Chemother. 1996 37: 145-160; doi:10.1093/jac/37.suppl_A.145 [Abstract] [PDF] [Request Permissions]  

P. Jaillon, J. Morganroth, I. Brumpt, G. Talbot, and The Sparfloxacin Safety Group
Overview of electrocardiographic and cardiovascular safety data for sparfloxacin
J. Antimicrob. Chemother. 1996 37: 161-167; doi:10.1093/jac/37.suppl_A.161 [Abstract] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.